The Royal College of Radiologists has worked with the British Nuclear Medicine Society and the UK Radiopharmacy Group to produce practical guidance to help nuclear medicine teams plan radioisotope work in case of a no-deal Brexit.
Practical advice for radiopharmacy and nuclear medicine services in the event of a no-deal Brexit outlines industry updates on supplier preparedness for tracer and therapeutic radioisotope supply in the event of no-deal, and urges clinicians to liaise directly with their suppliers for information on individual products.
It contains advice to help services produce individual risk assessments, emphasising the importance of communication and supply networking between hospitals.
The guidance contains practical advice on procurement changes and considerations for workload planning and case prioritisation depending on supply alterations.
The planning document also lists product alternatives and substitutions for particular imaging procedures, as well as key considerations for oncology teams faced with irregular supply.
No-deal Brexit guidance for nuclear medicine teams
Tuesday 5 March 2019